Nicola Groth

3.3k total citations · 1 hit paper
37 papers, 2.5k citations indexed

About

Nicola Groth is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Nicola Groth has authored 37 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 13 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Nicola Groth's work include Influenza Virus Research Studies (28 papers), Respiratory viral infections research (19 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Nicola Groth is often cited by papers focused on Influenza Virus Research Studies (28 papers), Respiratory viral infections research (19 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Nicola Groth collaborates with scholars based in Italy, Germany and Switzerland. Nicola Groth's co-authors include Frauke Schultze‐Lutter, Nina Schnyder, Radoslaw Panczak, Michele Pellegrini, Giovanni Apolone, Astrid Borkowski, Karl G. Nicholson, Katja Höschler, Helen Dillon and Tristan Clark and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Nicola Groth

36 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association between mental health-related stigma and active help-seeking: Systematic review and meta-analysis

2017 428 citations Nina Schnyder, Radoslaw Panczak et al. The British Journal of Psychiatry profile →

Peers

Nicola Groth

EPIDE

IMMUN

Seth L. Welles United States

Mark G. Thompson United States

Aiqiang Xu China

Marc Steben Canada

Emma R. Miller Australia

Chun Kang South Korea

Mary S. Hayney United States

Xianbin Li China

Μαρία Τσολιά Greece

Shelley Rhodes United Kingdom

Seth L. Welles United States

Nicola Groth

699 ×0.5

EPIDE

1.3k ×2.2

294 ×0.6

IMMUN

275 ×0.7

272 ×0.7

Citations per year, relative to Nicola Groth Nicola Groth (= 1×) peers Seth L. Welles

Countries citing papers authored by Nicola Groth

Since Specialization

Citations

This map shows the geographic impact of Nicola Groth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Groth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Groth more than expected).

Fields of papers citing papers by Nicola Groth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Groth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Groth. The network helps show where Nicola Groth may publish in the future.

Co-authorship network of co-authors of Nicola Groth

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Groth. A scholar is included among the top collaborators of Nicola Groth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Groth. Nicola Groth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leroux‐Roels, Isabel, Jacques Bruhwyler, Nicola Groth, et al.. (2024). Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults. Vaccines. 12(12). 1391–1391. 2 indexed citations

Schnyder, Nina, Radoslaw Panczak, Nicola Groth, & Frauke Schultze‐Lutter. (2017). Association between mental health-related stigma and active help-seeking: Systematic review and meta-analysis. The British Journal of Psychiatry. 210(4). 261–268. 428 indexed citations breakdown →

Lewis, David, Odile Launay, Geert Leroux‐Roels, et al.. (2016). Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review. PLoS ONE. 11(8). e0157385–e0157385. 24 indexed citations

Cioppa, Giovanni Della, Uwe Nicolay, Kelly Lindert, et al.. (2014). A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration. Human Vaccines & Immunotherapeutics. 10(6). 1701–1710. 26 indexed citations

Cioppa, Giovanni Della, Uwe Nicolay, Kelly Lindert, et al.. (2012). Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59^®adjuvant. Human Vaccines & Immunotherapeutics. 8(2). 216–227. 30 indexed citations

Villa, Marco, et al.. (2012). Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy. American Journal of Epidemiology. 176(6). 527–533. 132 indexed citations

Rivera, Luis, et al.. (2012). Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults. Vaccine. 30(35). 5285–5292. 3 indexed citations

Tregnaghi, Miguel, Daniel Stamboulián, Elena Fragapane, et al.. (2012). Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study.. PubMed. 25(3). 216–25. 5 indexed citations

Vesikari, Timo, Aino Forstén, Karl–Heinz Herbinger, et al.. (2011). Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. Vaccine. 30(7). 1388–1396. 49 indexed citations

10.

Frey, Sharon E., Timo Vesikari, Maria Lattanzi, et al.. (2010). Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults. Clinical Infectious Diseases. 51(9). 997–1004. 117 indexed citations

11.

Ambrozaitis, Arvydas, et al.. (2009). A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine. Vaccine. 27(43). 6022–6029. 29 indexed citations

12.

Groth, Nicola, Roberto Bugarini, Maria Lattanzi, et al.. (2009). Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture. The Journal of Infectious Diseases. 200(6). 841–848. 62 indexed citations

13.

Pellegrini, Michele, Uwe Nicolay, Kelly Lindert, Nicola Groth, & Giovanni Della Cioppa. (2009). MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database. Vaccine. 27(49). 6959–6965. 139 indexed citations

14.

Clark, Tristan, Manish Pareek, Katja Höschler, et al.. (2009). Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine. New England Journal of Medicine. 361(25). 2424–2435. 377 indexed citations

15.

Keitel, Wendy A., Nicola Groth, Maria Lattanzi, et al.. (2009). Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial. Vaccine. 28(3). 840–848. 61 indexed citations

16.

Vesikari, Timo, Nicola Groth, Aino Karvonen, Astrid Borkowski, & Michele Pellegrini. (2009). MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination. Vaccine. 27(45). 6291–6295. 115 indexed citations

17.

Vesikari, Timo, Michele Pellegrini, Aino Karvonen, et al.. (2009). Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant. The Pediatric Infectious Disease Journal. 28(7). 563–571. 155 indexed citations

18.

Banzhoff, Angelika, Michele Pellegrini, Giuseppe Del Giudice, et al.. (2008). MF59^®‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza and Other Respiratory Viruses. 2(6). 243–249. 59 indexed citations

19.

Groth, Nicola, Emanuele Montomoli, Cosimo Gentile, et al.. (2008). Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial. Vaccine. 27(5). 786–791. 36 indexed citations

20.

Negri, Eva, Carla Colombo, Laura Giordano, et al.. (2004). Influenza vaccine in healthy children: a meta-analysis. Vaccine. 23(22). 2851–2861. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact